EVEASXEVE Health Group Limited

EVE price activity

Last Price

Change (24hr)

AUD (%)

Volume

Volume (4w avg)

Previous Close

N/A

Last Trade

EVE price performance

-6.25%

-11.76%

-28.57%

YTD

-51.61%

EVE price fundamentals

N/A

Shares Issued

N/A

Earnings Per Share (EPS)

N/A

Dividends Per Share (DPS)

N/A

P/E Ratio

Price market cap

Market cap

N/A

AU-ASX rank

N/A

Sector Rank

N/A

EVE details

View company website

View AU-ASX Official Page

EVE dividends

EVE Market Signals

More ways to discover

Browse Australia news Discover ASX signals Browse all ASX stocks Browse all ASX ETFs

EVE Health Group Limited (AU-ASX: EVE)

EVE Health Group Limited, together with its subsidiaries, engages in the development, retail, and commercialization of health and wellness, and pharmaceutical products. The company lead product is Dyspro, a proprietary pharmaceutical-grade formulation to address dysmenorrhea (menstrual pain); and Libbo, a proprietary pharmaceutical-grade oral dissolving film formulation for the treatment of erectile dysfunction. It also offers Lactobacillus rhamnosus Beebiotic MAP01, a proprietary strain to support digestive health and vitality. The company was formerly known as EVE Investments Limited. EVE Health Group Limited was incorporated in 2003 and is based in Subiaco, Australia.

Price: A$0.02

Sector: Consumer Defensive — Packaged Foods